We are live on ! Find out more
JHP

James Hambro & Partners Portfolio holdings

AUM $2.76B
1-Year Est. Return 19.67%
This Fund
S&P 500
This Quarter Est. Return
-2.37%
1 Year Est. Return
+19.67%
3 Year Est. Return
+79.16%
5 Year Est. Return
+89.36%
10 Year Est. Return
AUM
$1.54B
AUM Growth
+$27.7M
Cap. Flow
+$66.5M
Cap. Flow %
4.31%
Top 10 Hldgs %
59.28%
Holding
63
New
3
Increased
19
Reduced
19
Closed
9

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$97.9M
2
AON icon
Aon
AON
+$67.4M
3
DHR icon
Danaher
DHR
+$40M
4
ISRG icon
Intuitive Surgical
ISRG
+$14.6M
5
UNH icon
UnitedHealth
UNH
+$9.63M

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$12M
2
IBM icon
IBM
IBM
+$11.5M
3
JPM icon
JPMorgan Chase
JPM
+$1.93M
4
TJX icon
TJX Companies
TJX
+$1.16M
5
PFE icon
Pfizer
PFE
+$1.05M

Sector Composition

Rank Sector Weight
1 Financials 26.45%
2 Technology 20.84%
3 Healthcare 18.37%
4 Industrials 8.54%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
51
PepsiCo
PEP
$190B
$305K 0.02%
1,799
NVDA icon
52
NVIDIA
NVDA
$4.86T
$303K 0.02%
6,960
+40
+0.6% +$1.79K
ABT icon
53
Abbott
ABT
$183B
$295K 0.02%
3,050
VFH icon
54
Vanguard Financials ETF
VFH
$13.5B
$215K 0.01%
2,680
ITW icon
55
Illinois Tool Works
ITW
$82.6B
-800
Closed -$200K
MRK icon
56
Merck
MRK
$322B
-1,865
Closed -$215K
NEE icon
57
NextEra Energy
NEE
$181B
-3,135
Closed -$233K
PFE icon
58
Pfizer
PFE
$143B
-28,700
Closed -$1.05M
PODD icon
59
Insulet
PODD
$11.5B
-915
Closed -$264K

Similar funds

James Hambro & Partners's Q3 2023 Portfolio in Review

As of Q3 2023, James Hambro & Partners held 63 positions worth $1.54B, up 1.8% from $1.52B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

James Hambro & Partners deployed $66.5M of net new capital in Q3 2023, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Linde: 257,126 shares worth $95.8M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Union Pacific, an estimated $12M trimmed.

  • James Hambro & Partners's largest Q3 2023 buy was Linde: 257,126 shares worth $95.8M.
  • James Hambro & Partners added most to Danaher in Q3 2023, an estimated $40M increase.
  • James Hambro & Partners's biggest Q3 2023 reduction was Union Pacific, cutting an estimated $12M.
  • James Hambro & Partners fully exited Pfizer in Q3 2023, selling an estimated $1.05M.
  • James Hambro & Partners's ten largest holdings make up 59% of its $1.54B portfolio in Q3 2023.
  • James Hambro & Partners opened 3 new positions and closed 9 in Q3 2023.
  • James Hambro & Partners's portfolio value rose 1.8% quarter-over-quarter to $1.54B.

Based on James Hambro & Partners's 13F filing for Q3 2023, filed 24 Oct 2023.